ROP

When a Premature Baby Needs Eye Treatment

For parents of a premature baby, the first weeks of life can be emotionally intense. Your child may be in a neonatal intensive care unit, growing stronger day by day, while many different specialists monitor breathing, feeding, infection risk, brain development and other aspects of early life. In that setting, being told that your baby needs screening or treatment for retinopathy of prematurity, often called ROP, can feel frightening and unexpected.

ROP is a disease of the retina, the light-sensitive tissue at the back of the eye. It occurs only in premature infants because the retinal blood vessels are not fully developed at birth. In many babies, mild ROP improves on its own as the eye matures. In some infants, however, abnormal blood vessel growth can progress quickly and may lead to retinal scarring, retinal detachment and permanent vision loss if it is not detected and treated at the right time.

The purpose of ROP care is not simply to perform a procedure. It is to identify which babies are at risk, examine the retina at the correct intervals, recognize the stage and location of disease, and intervene before the retina is damaged. Timing is critical. A baby may look stable from the outside while changes inside the eye are evolving. This is why ROP care depends on a structured screening program and close coordination between neonatology and pediatric ophthalmology teams.

For international families, the concerns may be even broader. Parents may be asking whether their baby has been screened at the right time, whether treatment is urgent, whether laser or injection therapy is more appropriate, whether travel is safe, and what long-term follow-up will be needed. At Acibadem, ROP evaluation and treatment are approached within a multidisciplinary pediatric environment, with experienced physicians, modern diagnostic pathways and international patient support designed to help families understand each step clearly.

What ROP Treatment Is

ROP treatment refers to the medical and procedural care used to protect the retina in premature infants who develop sight-threatening retinopathy of prematurity. The treatment plan begins with careful eye screening and classification of the disease. If the ROP is mild and not likely to threaten vision, the baby may need observation with repeated examinations. If the disease reaches treatment criteria, intervention is recommended to reduce the risk of retinal detachment and severe visual impairment.

The two main active treatments are laser therapy and intravitreal injection therapy. Laser therapy uses controlled light energy to treat the peripheral areas of the retina that have not developed normal blood vessels. By treating these areas, laser therapy reduces the stimulus for abnormal vessel growth. Intravitreal injection therapy places a small amount of medication inside the eye, usually an anti-VEGF medicine, to reduce signals that drive abnormal blood vessel development. The choice depends on the baby’s gestational age, birth weight, general medical condition, the zone and stage of ROP, whether “plus disease” is present, and the judgment of the pediatric ophthalmology team.

In advanced cases, especially if retinal detachment has already begun, surgery may be considered. This can include procedures such as vitrectomy or other retinal surgery, but these are more complex and are generally used when earlier treatment has not been possible or when the disease has progressed despite care. The best chance of preserving vision is usually achieved through timely screening and treatment before advanced retinal detachment occurs.

ROP treatment is not a one-time decision isolated from the baby’s overall health. Premature infants may have breathing problems, heart issues, infections, anemia or other medical needs. Treatment planning therefore requires communication among neonatologists, pediatric ophthalmologists, anesthesiology teams when needed and nursing staff. In a hospital setting experienced with premature infants, this coordination helps treatment take place safely and at the right moment.

Who May Need ROP Screening and Treatment

ROP is primarily a condition of babies born very early or with very low birth weight. The more premature the infant, the greater the risk that retinal blood vessels are incomplete and vulnerable to abnormal development. Babies who have required oxygen support, prolonged intensive care, blood transfusions, treatment for infection or support for breathing may also be at higher risk. Some larger or more mature premature babies may still need screening if their neonatal course has been medically complicated.

Parents should understand that ROP usually does not cause visible symptoms in the early stages. A premature baby with developing ROP may not have red eyes, swelling, discharge or behavior that suggests an eye problem. Because newborns cannot describe vision and because the retina is hidden inside the eye, the condition can only be detected through a specialized eye examination.

Diagnosis is made by examining the retina after the pupils are dilated. A pediatric ophthalmologist uses instruments that allow visualization of the peripheral retina, where ROP often begins. In some cases, wide-field retinal imaging may be used to document the retinal findings, support follow-up comparisons and assist communication among specialists. These images do not replace the expertise of the examining physician, but they can be valuable in tracking disease over time.

ROP is described by several features. The “zone” indicates where the disease is located in the retina; disease closer to the optic nerve and central retina is generally more concerning. The “stage” describes how abnormal the blood vessel growth appears, ranging from a demarcation line to more advanced abnormal tissue and retinal detachment. “Plus disease” refers to abnormal dilation and twisting of blood vessels, which indicates active and aggressive disease. These details guide whether a baby should be observed closely or treated urgently.

Families may be referred for ROP care in several situations. A baby in a neonatal intensive care unit may be due for routine screening based on prematurity. Another infant may already have had an eye examination showing disease that requires treatment. Some parents seek a second opinion when they have been told that laser, injection therapy or surgery is needed. International families may also contact Acibadem when a premature baby is medically stable enough for transfer and requires coordinated ophthalmologic and neonatal evaluation.

Conditions and Indications Addressed by ROP Treatment

ROP treatment addresses retinal disease related to premature birth. It is intended for infants whose retinal findings suggest a meaningful risk of progression to scarring, traction or retinal detachment. The decision to treat is based on internationally recognized clinical criteria, adapted to the baby’s medical status and the ophthalmologist’s examination findings.

Common indications include Type 1 ROP, which generally requires treatment, and aggressive forms of ROP that can progress rapidly. Babies with ROP in posterior zones of the retina, significant plus disease or worsening retinal changes on serial examinations may need urgent intervention. Treatment may also be recommended when the disease pattern suggests that observation would carry too much risk.

Laser therapy and injection therapy are used to manage active abnormal blood vessel growth before it causes irreversible damage. In more advanced ROP, when partial retinal detachment or traction has developed, retinal surgery may be considered to reattach or stabilize the retina. However, outcomes are usually better when treatment is performed earlier in the course of disease, before the retinal structure has been severely distorted.

ROP care also addresses the long-term consequences associated with prematurity and retinal disease. Even after successful control of active ROP, children may have a higher risk of nearsightedness, astigmatism, strabismus, amblyopia or later retinal problems. For this reason, ROP treatment includes not only the immediate procedure but also a follow-up plan for visual development through infancy and childhood.

How ROP Treatment Is Performed

ROP treatment begins with preparation, and preparation begins with accurate assessment. Before any procedure, the pediatric ophthalmologist reviews the baby’s gestational age, birth weight, current age, neonatal course, oxygen needs, medications, feeding status and previous eye findings. The retina is examined after pupil dilation, and the severity and location of ROP are documented. When imaging is used, wide-field retinal photographs may help compare findings over time and provide a visual record for the care team and family.

If treatment is needed, the team discusses the recommended approach with the parents or legal guardians. This conversation usually covers why treatment is advised, what type of treatment is planned, what alternatives exist, what risks are involved and what follow-up will be necessary. Because ROP can progress quickly, some babies need treatment within a short time after diagnosis. The goal is to treat while the retina is still salvageable and before tractional changes become advanced.

For laser therapy, the baby is positioned carefully and monitored throughout the procedure. Depending on the infant’s condition and the hospital protocol, treatment may be performed in a neonatal intensive care setting or an operating room. Comfort measures, sedation or anesthesia support may be used according to the baby’s age, medical status and procedural needs. The ophthalmologist applies laser energy to the peripheral avascular retina through the dilated pupil. The laser spots are placed in a controlled pattern, avoiding the central retina responsible for detailed vision.

Laser treatment commonly takes less than two hours, although the exact duration varies depending on whether one or both eyes are treated and how extensive the avascular retina is. After the procedure, the baby is monitored for breathing, heart rate, oxygen saturation, temperature stability and feeding tolerance. Eye drops may be prescribed to reduce inflammation or prevent infection. The eyelids may appear swollen for a short period, and the baby may be more tired or irritable temporarily.

For intravitreal injection therapy, the procedure is typically brief, but it requires meticulous technique. The eye is numbed and cleaned using sterile precautions. A very fine needle is used to place medication inside the eye. The purpose is to reduce the abnormal vascular growth signals that are driving ROP activity. The infant is monitored during and after the injection, particularly because premature babies can be medically fragile even during short procedures.

Injection therapy can be especially useful in certain posterior or aggressive forms of ROP, but it requires careful long-term follow-up. In some infants, ROP can reactivate later after injection therapy, and the peripheral retina may remain immature for some time. Parents should be prepared for repeated examinations, sometimes over a longer period than after laser treatment. In selected cases, laser may still be needed later.

Advanced retinal surgery, such as vitrectomy, is performed when there is significant traction or retinal detachment. These procedures require specialized retinal surgical expertise and careful anesthesia planning. The surgeon works inside the eye using microsurgical instruments to relieve traction and attempt to stabilize or reattach the retina. Recovery and visual prognosis depend greatly on how advanced the detachment is and whether the central retina has been affected.

Technology supports each phase of ROP care. Indirect ophthalmoscopy allows detailed examination of the retina. Wide-field imaging can document disease patterns and assist follow-up. Laser systems deliver controlled energy to specific retinal areas. Microsurgical visualization and fine retinal instruments may be used for advanced cases. In the neonatal setting, continuous monitoring technology helps the team observe oxygen levels, heart rate and respiratory status during treatment. The value of these tools lies not in the equipment alone, but in how they are integrated into a disciplined clinical pathway for a very small and vulnerable patient.

After treatment, follow-up is essential. The ophthalmologist checks whether the abnormal vessel activity is regressing, whether plus disease is improving and whether additional treatment is needed. Early visits may occur within days to a week, then continue at intervals determined by the retinal findings. Even when the active ROP resolves, the child should continue pediatric eye follow-up to monitor vision development, refractive error and eye alignment.

Why Acting Early Matters

ROP is time-sensitive because the disease can progress from treatable abnormal vessel growth to retinal detachment within a relatively short period in some babies. The retina is delicate, and once scarring and traction pull it out of position, the possibility of restoring normal vision becomes much more limited. Early screening is therefore one of the most important parts of ROP care.

Delaying an examination may mean missing the window when treatment is most effective. Delaying treatment after high-risk ROP is identified may increase the chance of bleeding, scar tissue formation, distortion of the retina and detachment. In advanced disease, even skilled surgery may not be able to recover vision fully, particularly if the central retina has been damaged.

Acting early does not mean treating every premature baby. Many infants only need observation. It means following an evidence-based schedule, recognizing progression promptly and intervening when the risk of waiting becomes greater than the risk of treatment. For parents, keeping every scheduled ROP appointment is one of the most important ways to protect a premature child’s future vision.

Benefits of ROP Treatment

When ROP reaches treatment criteria, timely care can reduce the risk of severe retinal damage and support the best possible visual development for the child.

Benefit	What It Means for You
Protection against advanced retinal damage	Treatment aims to stop or slow abnormal blood vessel growth before it leads to scarring, traction or retinal detachment.
Better chance of preserving useful vision	Many babies treated at the appropriate time maintain functional vision, although long-term eye follow-up remains important.
Clearer decision-making	Structured screening and retinal documentation help parents understand whether observation, laser, injection therapy or surgery is recommended.
Care coordinated with neonatal needs	ROP treatment is planned around the baby’s breathing, feeding, oxygen requirements and overall medical stability.
Long-term visual monitoring	Follow-up helps detect refractive errors, lazy eye, strabismus or later retinal concerns that may need treatment during childhood.

Recovery Timeline After ROP Treatment

Recovery varies by the baby’s prematurity, general health, the severity of ROP and the type of treatment performed, but families can usually expect close observation and repeated eye examinations.

Time Period	What Patients Can Expect
Day 1	The baby is monitored for breathing, oxygen levels, heart rate and comfort. Mild eyelid swelling, redness or irritability may occur after laser or injection therapy.
First Week	The ophthalmologist may recheck the retina to confirm that the disease is beginning to regress and to decide whether additional treatment is needed.
First Month	Follow-up examinations continue. After injection therapy, monitoring may be especially important because the retina can remain immature and reactivation is possible.
Several Months	Active ROP often stabilizes or resolves, but the schedule depends on retinal vascular development and the baby’s clinical course.
Longer Term	Children who had ROP need pediatric ophthalmology follow-up to assess vision, glasses needs, eye alignment and retinal health as they grow.

Factors That Influence Outcomes

The outcome of ROP treatment depends on several medical and ophthalmic factors. One of the most important is the timing of diagnosis. Babies whose sight-threatening ROP is detected and treated before retinal detachment generally have a better chance of preserving vision than those who present later. The location of disease is also important. ROP in the posterior retina, closer to the optic nerve and macula, can be more aggressive and may require particularly careful management.

The stage of ROP and the presence of plus disease influence both urgency and prognosis. More advanced stages, significant vascular activity and rapid progression may increase the risk of complications. The baby’s overall health also matters. Extremely premature infants may have lung disease, heart conditions, infection risk or other challenges that affect procedural planning and recovery. Treatment must be tailored to the infant’s stability rather than approached as a routine eye procedure.

The choice of therapy can also shape the follow-up pathway. Laser therapy has a long history in ROP care and can be effective for many infants who meet treatment criteria. Injection therapy has become an important option for selected babies, particularly in certain posterior forms of disease, but it requires prolonged surveillance. Surgery for advanced retinal detachment is more complex, and visual recovery is less predictable because structural damage may already be present.

Another key factor is adherence to follow-up. ROP does not end the moment a procedure is completed. The retina must be checked until the physician is confident that the disease has regressed and the retinal vessels have matured sufficiently or the risk period has passed. Missing follow-up visits can allow reactivation or progression to go unnoticed. Families traveling internationally should have a clear follow-up plan before discharge, including what will be done at Acibadem and what should continue after returning home.

Long-term visual development is influenced by more than retinal attachment. Premature children may develop high myopia, astigmatism, amblyopia, strabismus or neurologic visual impairment related to prematurity. A good result therefore means not only avoiding retinal detachment but also monitoring how the child uses vision over time. Glasses, patching, eye alignment treatment or developmental support may be needed later. Early recognition of these issues can make a meaningful difference in a child’s functional vision.

Why International Patients Choose Acibadem for ROP Care

International families seeking ROP care often need more than a specialist appointment. They may need rapid review of medical records, coordination with a neonatal intensive care unit, safe scheduling of eye examinations, communication in their preferred language and a clear plan for treatment and follow-up. Acibadem’s international patient structure is designed to support these practical and medical needs while keeping the baby’s safety at the center of decision-making.

ROP care at Acibadem is delivered within hospitals accredited by Joint Commission International, with systems that emphasize patient safety, documentation and coordinated care. For premature infants, this structure is important because treatment may involve pediatric ophthalmologists, neonatologists, anesthesiology specialists, neonatal nurses and, in advanced cases, retinal surgeons. The baby’s oxygen needs, feeding status, infection risk and overall stability are considered alongside the retinal findings.

Multidisciplinary evaluation is especially valuable when the baby has complex prematurity-related conditions. Specialist discussions may help determine whether the infant can safely undergo laser therapy, whether injection therapy is more appropriate, whether additional imaging is needed, or whether advanced retinal surgery should be considered. Families receive recommendations based on the disease pattern and the baby’s medical condition, not a one-size-fits-all pathway.

Modern diagnostic and treatment tools support careful ROP management. Retinal examination instruments and wide-field imaging help document disease severity and monitor change. Laser therapy systems allow targeted treatment of the peripheral retina. Injection procedures are performed using sterile ophthalmic technique. When surgery is needed, microsurgical retinal methods may be used to address traction or detachment. These technologies are most effective when used by teams accustomed to caring for premature infants and coordinating with neonatal services.

For families arriving from abroad, Acibadem International can assist with appointment planning, medical record transfer, interpretation in more than 20 languages, hospital admission processes and communication between the family and care team. This can be particularly helpful when decisions are time-sensitive. Parents are guided on what reports are needed, such as birth history, gestational age, birth weight, oxygen support history, previous ROP examination notes, retinal images if available, and current neonatal status.

Personalized treatment planning is central to ROP care. A baby with early-stage disease may need close observation rather than immediate treatment. Another infant with posterior aggressive findings may need urgent intervention. A baby already treated elsewhere may need evaluation for regression, reactivation or complications. Acibadem’s role is to assess the current retinal status, explain the available options and create a plan that accounts for both medical urgency and the family’s international circumstances.

Families also value clear communication. ROP can be difficult to understand because the baby may appear outwardly stable while the retina is at risk. Physicians explain what they see in the eye, why treatment is or is not recommended, what the next examination will look for and what signs would require urgent attention. For parents making decisions far from home, this clarity can make a complex medical journey more manageable.

Taking the Next Step

If your premature baby has been diagnosed with ROP, has missed a scheduled screening or has been advised to undergo laser, injection therapy or retinal surgery, timely specialist evaluation is important. The earlier the retina is assessed accurately, the more options the care team may have to protect vision and reduce the risk of advanced disease.

Parents can request a consultation or second opinion by sharing the baby’s birth details, neonatal course, current medical status and previous eye examination reports. If retinal images are available, they may be helpful. The medical team can then advise whether urgent examination is needed, what type of care may be appropriate and how treatment and follow-up can be coordinated.

ROP care asks families to make decisions during a vulnerable time. With careful screening, evidence-based treatment and close follow-up, many infants with ROP can avoid the most serious retinal complications. The goal is to act at the right time, choose the right approach for the individual baby and support the child’s visual development long after the neonatal period has passed.

This information is general and is not a substitute for professional medical advice. Diagnosis and treatment decisions should be made by qualified physicians after evaluating the individual baby’s medical condition.